BRAND_ANALYSIS #BIONTECH HEALTH & PHARMA #24 OF 26 IN HEALTH & PHARMA ALIGNED

BioNTech

· Public · Updated 09 Jul 2026 08:27 UTC
#1096 of 1208 overall by tension · #24 of 26 in Health & Pharma
6 Aligned
The Balanced
Analysis

BioNTech's 6.19% stock gain and +0.20 sentiment suggest the mRNA vaccine narrative still moves markets, but C=40 reveals the biotech reality: essential to survival, irrelevant to culture. The company was famous for exactly 18 months.

IN THE NEWS (43 articles this week)
BioNTech has held talks with buyers over four German sites set to close, Handelsblatt says - Reuters
BioNTech and Pfizer score win in UPC dispute over COVID-19 vaccines against Promosome - JUVE Patent
BioNTech has reportedly contacted buyers over plans to exit German sites - Seeking Alpha
Cultural Score
40 / 100
Business Score
46 / 100
TENSION▁▁▂▁▁▁▁▂▁▁▁▁▁▁
CULTURAL▄▄▄▄▄▄▄▄▃▃▃▃▃▃
BUSINESS▃▃▂▃▃▃▃▂▃▃▄▄▄▄
Loading...
Wikipedia Momentum 15/40
News Presence 26/35
Search InterestRedistributed to other dimensions
Stock Momentum 24/30
Market Position 16/25
Revenue Growth 3/25
Earnings Health 3/20
Avg Daily (7d)116
Avg Daily (90d)168
7d/90d Ratio0.69x
Price$93.53
30d Change+6.2%
Market Cap$23.7B
Profit Margin-44.6%
BioNTech's tension is 6. Commerce outpacing culture. sociologyofcapitalism.com/brand/biontech
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/biontech.html" width="320" height="200" frameborder="0"></iframe>